论文部分内容阅读
目的探讨坦洛新联合西沙必利对糖尿病神经源性膀胱患者的治疗效果。方法治疗组患者服用坦洛新联合西沙必利,对照组患者服用谷维素,服用4周后,两组分别根据治疗前后每日排尿次数、每次尿量、B超测得残余尿量进行比较。结果治疗组患者治疗后较治疗前每日排尿次数明显减少、每次尿量明显增多、B超测得残余尿量明显减少,差异有统计学意义(P<0.05)。对照组治疗前后每日排尿次数、每次尿量、B超测得残余尿量无明显差异(P>0.05)。结论坦洛新联合西沙必利对糖尿病神经源性膀胱患者的治疗效果肯定,可用于临床推广。
Objective To investigate the effect of tamsulosin and cisapride on diabetic neurogenic bladder patients. Methods Patients in the treatment group received tamsulosin plus cisapride, while those in the control group took oryzanol. After taking for 4 weeks, the two groups were compared according to the number of urination, urine output and B-ultrasound residual urine volume before and after treatment. Results After treatment, the number of urination in patients in treatment group decreased significantly, the urine output increased significantly and the residual urine volume in B ultrasound decreased significantly. The difference was statistically significant (P <0.05). Before and after treatment in the control group, the frequency of urination, urine volume per time, residual urine volume measured by B-ultrasound had no significant difference (P> 0.05). Conclusion The combination of tamsulosin and cisapride in the treatment of diabetic neurogenic bladder patients is effective and can be used for clinical promotion.